Therapeutic Asset Ratings
3,272 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Ipilimumab
Urethra Clear Cell Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ipilimumab
Urethra Squamous Cell Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ipilimumab
Vaginal Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ipilimumab
Vaginal Squamous Cell Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ivosidenib
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ivosidenib
Histiocytic Sarcoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ivosidenib
Juvenile Xanthogranuloma
National Cancer Institute (NCI)
P2
CCC
(53)
Ivosidenib
Langerhans Cell Histiocytosis
National Cancer Institute (NCI)
P2
CCC
(53)
Ivosidenib
Malignant Glioma
National Cancer Institute (NCI)
P2
CCC
(53)
Ivosidenib
Rhabdomyosarcoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ivosidenib
Ependymoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ivosidenib
Ewing Sarcoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ivosidenib
Hepatoblastoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ivosidenib
Malignant Germ Cell Tumor
National Cancer Institute (NCI)
P2
CCC
(53)
Ivosidenib
Medulloblastoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ivosidenib
Neuroblastoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ivosidenib
Osteosarcoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ivosidenib
Peripheral Primitive Neuroectodermal Tumor
National Cancer Institute (NCI)
P2
CCC
(53)
Ivosidenib
Central Nervous System Neoplasm
National Cancer Institute (NCI)
P2
CCC
(53)
Ivosidenib
Rhabdoid Tumor
National Cancer Institute (NCI)
P2
CCC
(53)
Ivosidenib
Soft Tissue Sarcoma
National Cancer Institute (NCI)
P2
CCC
(53)
Ivosidenib
Grade II Glioma
National Cancer Institute (NCI)
P2
CCC
(53)
Ivosidenib
Refractory Malignant Neoplasm
National Cancer Institute (NCI)
P2
CCC
(53)
Ivosidenib
Wilms Tumor
National Cancer Institute (NCI)
P2
CCC
(53)
Kras Tcr-Transduced Pbl
Duodenum Cancer
National Cancer Institute (NCI)
P2
CCC
(53)
Showing 1576 to 1600 of 3,272 assets
Previous
Page 64 of 131
Next